JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 9.58% |
| 3 | Consumer Discretionary | 9.07% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IBDQ
3501
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $2.56M | ﹤0.01% |
102,987
+664
| +0.6% | +$16.4K |
|
3502
Invesco China Technology ETF
CQQQ
$3.18B
| $2.55M | ﹤0.01% |
79,679
-2,252
| -3% | -$71.4K |
|
3503
PUT
NIO
NIO
$11.3B
| $2.55M | ﹤0.01% |
+566,300
| New | +$3.41M |
|
|
INBX
3504
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $2.54M | ﹤0.01% |
72,764
+21,238
| +41% | +$775K |
|
3505
Columbia Research Enhanced Core ETF
RECS
$6.1B
| $2.54M | ﹤0.01% |
82,085
+13,737
| +20% | +$402K |
|
3506
CALL
Ambarella
AMBA
$3.6B
| $2.54M | ﹤0.01% |
+50,000
| New | +$2.73M |
|
|
3507
PUT
Ambarella
AMBA
$3.6B
| $2.54M | ﹤0.01% |
+50,000
| New | +$2.73M |
|
|
QHY
3508
WisdomTree U.S. High Yield Corporate Bond Fund
QHY
$243M
| $2.54M | ﹤0.01% |
56,018
+2,892
| +5% | +$131K |
|
3509
CALL
West Pharmaceutical
WST
$24.6B
| $2.53M | ﹤0.01% |
6,400
+5,000
| +357% | +$1.85M |
|
|
AVNS
3510
DELISTED
Avanos Medical
AVNS
| $2.53M | ﹤0.01% |
127,118
-76,110
| -37% | -$1.47M |
|
3511
Healthcare Services Group
HCSG
$1.48B
| $2.53M | ﹤0.01% |
202,662
-101,867
| -33% | -$1.13M |
|
3512
CALL
Cytokinetics
CYTK
$10.3B
| $2.52M | ﹤0.01% |
36,000
+23,500
| +188% | +$1.82M |
|
3513
Ameresco
AMRC
$1.48B
| $2.52M | ﹤0.01% |
104,411
+3,228
| +3% | +$72.3K |
|
3514
PUT
Alpha Metallurgical Resources
AMR
$2.11B
| $2.52M | ﹤0.01% |
+7,600
| New | +$2.79M |
|
3515
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $2.51M | ﹤0.01% |
161,509
+11,323
| +8% | +$183K |
|
3516
Origin Bancorp
OBK
$1.68B
| $2.51M | ﹤0.01% |
80,281
+10,850
| +16% | +$337K |
|
|
SRTA
3517
Strata Critical Medical Inc
SRTA
$522M
| $2.5M | ﹤0.01% |
878,675
+164,990
| +23% | +$509K |
|
3518
CALL
Johnson Controls International
JCI
$93.1B
| $2.5M | ﹤0.01% |
38,300
+14,700
| +62% | +$856K |
|
3519
ALPS Equal Sector Weight ETF
EQL
$769M
| $2.5M | ﹤0.01% |
63,606
+618
| +1% | +$23.1K |
|
3520
FT Vest US Equity Deep Buffer ETF January
DJAN
$483M
| $2.5M | ﹤0.01% |
69,354
+69,180
| +39,759% | +$2.44M |
|
3521
Energy Recovery
ERII
$426M
| $2.5M | ﹤0.01% |
158,232
+80,306
| +103% | +$1.28M |
|
3522
iShares MSCI Italy ETF
EWI
$1.08B
| $2.49M | ﹤0.01% |
66,041
+21,976
| +50% | +$769K |
|
3523
iShares MSCI Spain ETF
EWP
$2.22B
| $2.49M | ﹤0.01% |
77,427
+55,413
| +252% | +$1.67M |
|
3524
A10 Networks
ATEN
$1.99B
| $2.49M | ﹤0.01% |
181,834
+6,856
| +4% | +$92.2K |
|
3525
Global X MLP & Energy Infrastructure ETF
MLPX
$3.62B
| $2.49M | ﹤0.01% |
50,791
-255,986
| -83% | -$11.7M |
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $43.6B of net new capital in Q1 2024, opening 625 new positions and adding to 3,258 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 766 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.